Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-620244
Filing Date
2016-06-13
Accepted
2016-06-13 16:54:53
Documents
2
Period of Report
2016-06-13

Document Format Files

Seq Description Document Type Size
1 6-K d214027d6k.htm 6-K 10588
2 EX-99.1 d214027dex991.htm EX-99.1 7643
  Complete submission text file 0001193125-16-620244.txt   19199
Mailing Address JOUKAHAISENKATU 6 TURKU H9 FI-20520
Business Address JOUKAHAISENKATU 6 TURKU H9 FI-20520 358-2-274-8900
Biotie Therapies Corp. (Filer) CIK: 0001579695 (see all company filings)

EIN.: 000000000 | State of Incorp.: H9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37423 | Film No.: 161711261
SIC: 2834 Pharmaceutical Preparations